Skip to content

Clinical trials

Phase 3 Stroke trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: Netherlands Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20054
20063
20071
20082
20101
20111
20121
20134
20141
20161
20171
20181
20191
20201
20211
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated6
Recruiting3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Bayer2
Boehringer Ingelheim2
Janssen Research & Development, LLC2
Pfizer2
Sanofi2
The George Institute2
AstraZeneca1
CSL Behring1
Columbia University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke30
Myocardial Infarction11
Cardiovascular Diseases8
Atrial Fibrillation6
Ischemic Stroke5
Coronary Artery Disease4
Heart Diseases4
Heart Failure3
Hyperlipidemias3
Peripheral Arterial Disease3

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.